COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
| Author | |
|---|---|
| Abstract | :
It is reasonable to think that cancer patients undergoing chemotherapy, targeted therapy or immunotherapy could have a more aggressive course if positive for Coronavirus disease CoV-2 (COVID- 19). |
| Year of Publication | :
2020
|
| Journal | :
Critical reviews in oncology/hematology
|
| Volume | :
152
|
| Number of Pages | :
102991
|
| ISSN Number | :
1040-8428
|
| URL | :
https://linkinghub.elsevier.com/retrieve/pii/S1040-8428(20)30129-3
|
| DOI | :
10.1016/j.critrevonc.2020.102991
|
| Short Title | :
Crit Rev Oncol Hematol
|
| Download citation |